AdThe Forefront of MS Research is Changing. Learn More about the Evolving Science. Explore the Research on Multiple Sclerosis and Disability Progression
AdLearn About A Newly Approved Treatment For Patients With mIDH1 Grade 2 Glioma. Learn About A New Treatment Option For mIDH1 Grade 2 Astrcytoma and Oligodendroglioma.
Types: Important Safety Info, FAQs, Support For Patients, Full Prescribing Info